about
Salivary biomarkers: toward future clinical and diagnostic utilitiesRecommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary AnalysisOral Biofluid Biomarker Research: Current Status and Emerging FrontiersPlasma proteomic profiling in HIV-1 infected methamphetamine abusersAptamer-based multiplexed proteomic technology for biomarker discoveryAdvancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid BiopsyAssessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney diseaseSalivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances.Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis.Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis researchEnrichment of phosphorylated peptides and proteins by selective precipitation methods.Screening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors.Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer arraySerum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys.Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges.Systematic antibody and antigen-based proteomic profiling with microarrays.A critical appraisal of techniques, software packages, and standards for quantitative proteomic analysis.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines.Efficient separations of intact proteins using slip-flow with nano-liquid chromatography-mass spectrometry.Stripping voltammetric detection of insulin at liquid-liquid microinterfaces in the presence of bovine albumin.Maternal serum CA 19-9 and CA 15-3 levels in pregnancies affected by trisomy 21.iTRAQ Quantitative Proteomic Analysis of Vitreous from Patients with Retinal Detachment.Evolution of proteomic biomarker for chronic liver disease: Promise into reality.
P2860
Q26851200-6A1D73D0-1148-4EC0-96F4-F6E8768385D9Q28076129-C2953860-BA68-4598-BEC0-328D24CA4842Q28077072-3F535A05-7A7A-49C9-8086-A7EB03801D84Q28480898-9473B155-F025-4B9C-9399-A4C1839E412EQ28744329-BA68C176-19F8-4EE1-B65C-17416FDBF74AQ33455416-9DBCBC4C-61C5-43CD-BA6E-C5BB6E3FF6EAQ33591146-CE9B2C16-2A8E-4627-B216-1E8DBAF9D63CQ33683154-B5AAB04D-E4A1-4E74-8246-FAC63F2186D6Q33940116-6800F035-EC11-4BA0-915B-F2C9F9BD8926Q34481890-5117119A-CBE4-4EFA-9E75-CF87E2026C34Q34504341-146B2164-FD25-40D9-8DD5-53939B2C046BQ35542665-6FB118D1-1D5E-4FF9-9188-2C55CBCE38E2Q35690288-71640D4A-700B-419A-8820-054F4AE6BC92Q35951935-9750F59B-BB9F-4BFD-9E11-C190A4351E89Q37266056-6C6C6A56-34F4-4AAE-BED8-F05D712A5D89Q37363395-0025871D-8573-4308-8CA9-CFB284A0CBF5Q37853185-C3C3D093-A839-48F3-B662-FA7E14706C03Q38026929-BB31E761-5C19-428D-AE7C-58D2E78BF7B5Q38045278-68C05BE3-684A-4D87-8029-1A10907387FEQ38312065-3F109C19-E30D-4DE4-8F81-1E80694FA517Q38699671-4445B7B4-8728-456F-9137-9B79C4A13AFBQ44537946-FE3BE8A0-A015-4433-AD5B-698FB0241234Q49122019-BD6F26D4-9138-4877-8D4F-5337FC25F0D0Q52325130-D9F22E70-727E-46CD-A7B0-4CF4F4E3EE9AQ55091571-681084E2-EE35-46A8-96FC-75C508BF771D
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Biomarker discovery and clinical proteomics.
@ast
Biomarker discovery and clinical proteomics.
@en
type
label
Biomarker discovery and clinical proteomics.
@ast
Biomarker discovery and clinical proteomics.
@en
prefLabel
Biomarker discovery and clinical proteomics.
@ast
Biomarker discovery and clinical proteomics.
@en
P2860
P1476
Biomarker discovery and clinical proteomics.
@en
P2093
Jerzy Silberring
Pawel Ciborowski
P2860
P356
10.1016/J.TRAC.2009.11.007
P577
2010-02-01T00:00:00Z